- Home
-
Technical Platform
-
Services
- TCR-T Lead Sequence Development Service
- Immune CAR Cell Preparation Technology Service
- Antibody Coupled Drug Discovery Service
- Antibody Affinity Maturation Service
- Antibody Humanization Services
- Bispecific Antibody Development Services
- Antibody Protein Sequencing Service
- Antibody Affinity Determination Service
Antibody Drugability Assessment
- Aptamer-Drug Conjugate (ApDC) Development Services
- Nuclide Nucleic Acid Aptamer Screening Service
- Nucleic Acid Aptamer Synthesis Service
- Nucleic Acid Aptamer Modification Service
- Nucleic Acid Aptamer Library Construction Service
- Bispecific Aptamer Development Service
- Protein Nucleic Acid Aptamer Screening Service
- Metal Ion Nucleic Acid Aptamer Screening Service
- Small Molecule Nucleic Acid Aptamer Screening Service
- Cell Nucleic Acid Aptamer Screening Service
- Peptide Affinity Maturation Services
- Peptide-Drug Conjugate (PDC) Development Services
- Stapled Peptide Development Services
- Targeted Peptide Library Screening Service
- Targeted Peptide Library Construction Service
Active Peptide Discovery Technology Service
- mRNA Antibody Production Services
- mRNA Immunogen Production Service
- DNA Immune Antibody Preparation Service
Animal Immunization Technology Services
- Yeast Two-hybrid (Nuclear System) Service
- Yeast Two-hybrid (Membrane System) Service
- Yeast cDNA Library Construction Technology Service
- Yeast One Hybrid Service
Yeast Hybrid Technology Platform
- Recombinant Chimeric Antibodies Customized Services
- Recombinant IgG Customization Services
- Recombinant Fragment Antibody Customization Service
Recombinant Antibody Expression Services
-
Technical Support
- Nanobodies: How a 15 kDa Single-Domain Antibody Breaks Through the Limits of Conventional Therapy
- Structural Basis for Selectivity and Antagonism in GPCR-Nanobodies
- Novel Peptide-Drug Conjugate (PDC) Shows Efficacy in Hepatocellular Carcinoma Models
- Nanobody Expression in Insect Cells
- Nanobody Mammalian Cell Expression
- Single-chain Antibody Library Construction Technology Introduction
- Prokaryotic Expression of Nanobodies
- Cell Line Immunogen of Nanobody
- Construction of Single Chain Antibody Library
- Nano-antibody/Single Domain Antibody Library Construction Service
- Recombinant Expression Strategies for Bispecific Antibodies: What You Need to Know？
- Antibody Engineering and Modification: Maximizing Therapeutic and Diagnostic Utility
- Bispecific Antibodies (bsAbs): Mechanisms of Action Explained
- Applications of bispecific antibodies in cancer therapy
- Beyond PD-1 Blockade: How BiCE Bridges T Cells and cDC1s to Unlock Cold Tumors
- From Purity to Functionality: A Comprehensive Guide to Recombinant Antibody Quality Control Standards
- How much do you know about the molecular design and mechanism of action of ADC drugs?
- The ADC linker serves as a crucial "bridge" component.
- ADCs are becoming increasingly mature in the field of tumor therapy.
- Cracking the Immune System’s “Source Code”: Why Is B-Cell Technology the Ultimate Path to Antibody Discovery?
Special topic on antibody modification
- After the Halo Fades: How Antibody Discovery Is Returning to Science — and to Systems
- From Cell Line to Purified Drug Substance: How Therapeutic Antibodies Are Manufactured in Mammalian Cells
- High-Throughput Yeast Display Platform for Macrocyclic Peptide Discovery
- How Are Antibody Drugs Produced? A Deep Dive into Mammalian Cell Culture and Purification Processes
- Expression of Recombinant Antibodies in Mammalian Cells: Core Technologies – Comprehensive Analysis of Host Selection and Purification Strategies
- Bacteriophages, yeast, mRNA display: Who is the champion of the display technology?
- Breakthrough: Ultra-High Sensitivity Detection of Legionella Using an Aptamer-Based Electrochemical Sensor
- Construction of yeast hybrid library: Gateway technology
- Eukaryotic System-Based Targeted Drug Discovery Platform: Yeast Display Technology
- Common Problems and Solutions for Yeast Two-hybrid Experiments
Yeast Display Technology Special Topic
- Empowering Precision Medicine: The "Magic Scissors" and "Master Strokes" of Antibody Engineering
- Humanization calculation method and structural feature analysis of nanobodies！
- Stop Sticking with Hybridoma! A Primer on the Three Generations of Antibody Discovery Technology
- Rationale and Significance of Bispecific Antibody Development
- Protein Not Expressing? You Might Have Chosen the Wrong Tag!
- What to Do After Protein Purification? These Four Validation Methods You Must Know!
- Yeast Two-Hybrid Technology Reveals a Novel Mechanism of Wheat Disease Resistance: How TaPIR1 "Hijacks" TaHRP1 to Suppress Chloroplast Function?
- Yeast Hybrid Library Construction: Smart Technology
- New Molecular Interaction Technology: How Much Do You Know About Yeast Hybridization Technology?
- Antibody Affinity Testing(SPR)
Antibody Detection Service Topic
- Peptide-Targeted Nanoparticles for Tumor Therapy: Vascular Homing Peptides Review
- Frontiers in Targeted Drug Development: Comparison and Application of Various Peptide Screening Methods
- Application of phage display (Part 2)
- Application of phage display (Part 1)
- Phage Display
- Technical Article: Detailed Guide to Phage Screening
- Frontiers in Targeted Drug Development: Comparison and Application of Multiple Peptide Screening Methods
- Revolutionary Advances in Single-Domain Antibody Development and Applications
- New Method for Discovering Targeted Drugs: Screening of Peptide Libraries Based on Phage Display Technology
- How much do you know about IgG, Fab, scFv, and VHH?
Special Topic on Phage Display Technology
- CD7-targeted Antibody-Drug Conjugates: A New Hope for T-Cell Acute Lymphoblastic Leukemia
- Discovery of targeted nucleic acid small molecules: Cell-SELEX technology
- A Promising Novel Cancer Therapeutic Strategy: Aptamer-Drug Conjugates (ApDCs)
- A Novel Therapeutic Approach for Multiple Myeloma: Development of a CD38 and CD47 Bispecific Bipartopic Antibody
- A Novel Therapeutic Approach - CAR-M
- Application And Prospects of CAR-T Technology in Tumor Immunotherapy
- CAR-T Discovery Service
CAR-T Molecule Discovery Topic
- Stop Screening Aptamers the Old Way: The Decisive Advantage of Magnetic-Bead SELEX
- Magnetic Beads: How Do They Make SELEX Technology Fast, Precise, and Reliable?
- Screening and optimization of nucleic acid aptamers
- Main Research Directions Progress and Challenges of Nucleic Acid Aptamer Screening Technology
- Research Progress of Protein Nucleic Acid Aptamer Screening
- Nucleic Acid Aptamer Libraries Screening: an Efficient Method for Discovering Specific Binding Molecules
Special topic on adapter development
- In Vivo Screening Services – Animal Models
- The Promise of Small Nucleic Acid Therapeutics: From Bench to Clinic as Next-Generation Medicines
- Issues Related to Aptamer Library Screening
- Introduction to Nucleic Acid Aptamer Library Screening Technology
- Screening and Application of Peptide Aptamers
- Research Progress of Aptamer Screening-of Small Molecule Targets
Molecular Biology Service Topics
-
Product Center
- Contact Us
Tek Biotech has M13, T4 and T7 phage display systems. According to the customer's project requirements (parameters such as the size of the displayed protein or antibody fragment), different phages will be used to display proteins or antibodies.
TekBiotech can provide customers with yeast display library construction and screening services for camel-derived VHH nanoantibody libraries and scFv antibodies from other species.
TekBiotech has mature animal PBMC isolation technology to ensure that cells are not damaged or stimulated during the separation process. The subsequent purification technology ensures the purity and viability of camel mononuclear cells and other technical indicators, which is suitable for subsequent cell culture, antibody preparation and other research.
Based on the phage display technology platform, TekBiotech can provide major experimental links including antigen design, alpaca immunization, library construction and screening (solid/liquid screening), and active function verification, and provide highly specific and high-affinity camelid VHH antibodies to scientists around the world.
With its leading technology platform and rich experience, Tek Biotech provides global customers with complete solutions from the discovery, design to production and application of nanoantibodies.
TekBiotech has been committed to protein expression and sequencing research for many years. Based on high-resolution mass spectrometry and high-fidelity gene cloning technology, we are able to provide customers with high-fidelity antibody and protein sequencing services.
Tek Biotech provides comprehensive yeast one-hybrid services, focusing on studying DNA-protein interactions. Our services include transcription factor identification, target gene cloning, and gene regulation studies. Choose Tek Biotech and enjoy customized, highly sensitive yeast one-hybrid solutions.
After years of technological accumulation, Tek Biotech has built a complete phage display technology system and yeast display system to provide customers with high-quality Car lead antibody molecule discovery services.
Tek Biotech has mature antibody humanization technology and is committed to building a complete one-stop technical service platform. It can provide a series of services from bioinformatics analysis, humanized antibody design, antibody expression and purification, to affinity determination, antibody affinity maturation, etc. to meet the needs of different customers.
Tek Biotech is committed to providing excellent nano-antibody services, especially in the preparation of different immunogens. We use advanced technologies to efficiently prepare nano-antibodies against a variety of immunogens, including proteins, peptides, viruses, cells and small molecules.
